The Board of Directors of Chong Kun Dang Pharmaceutical Corp. has authorized a buyback plan on February 10, 2022.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
106,000 KRW | +6.00% | +3.21% | -19.02% |
EPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-19.02% | 989M | |
+18.04% | 42.95B | |
+16.92% | 21.38B | |
+18.33% | 15.05B | |
+19.27% | 14.45B | |
+56.12% | 13.04B | |
-0.05% | 6.79B | |
-10.73% | 6.72B | |
-8.87% | 5.73B | |
+11.21% | 5.47B |
- Stock Market
- Equities
- A185750 Stock
- News Chong Kun Dang Pharmaceutical Corp.
- Chong Kun Dang Pharmaceutical Corp. authorizes a Buyback Plan.